Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEdinburgh Investment Trust PLC Regulatory News (EDIN)

Share Price Information for Edinburgh Investment Trust PLC (EDIN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 722.00
Bid: 721.00
Ask: 723.00
Change: 5.00 (0.70%)
Spread: 2.00 (0.277%)
Open: 715.00
High: 723.00
Low: 715.00
Prev. Close: 717.00
EDIN Live PriceLast checked at -
Edinburgh Investment is an Investment Trust

To achieve an increase of the NAV per share in excess of the growth in the FTSE All-Share Index and dividend growth that exceeds UK inflation rate by investing primarily in UK securities.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

24 Nov 2016 07:00

EDINBURGH INVESTMENT TRUST PLC - Half-year Report

EDINBURGH INVESTMENT TRUST PLC - Half-year Report

PR Newswire

London, November 23

The Edinburgh Investment Trust plc

Half-Yearly Financial Report

Six Months to 30 September 2016

FINANCIAL INFORMATION AND PERFORMANCE STATISTICS

The Edinburgh Investment Trust plc (the ‘Company’) is a UK investment trust listed on the London Stock Exchange.

Investment Objective of the Company

The Company invests primarily in UK securities with the long term objective of achieving:

1. an increase of the Net Asset Value per share in excess of the growth in the FTSE All-Share Index; and

2. growth in dividends per share in excess of the rate of UK inflation.

Performance Statistics

FOR THE SIX MONTHS TO 30 SEPTEMBER2016
% CHANGE
Total Return (capital growth with
income reinvested)
Net asset value (NAV) total return(1)
– debt at par+6.8
– debt at market value+6.6
Share price total return(1)+11.1
FTSE All-Share Index total return(1)+12.9

ATAT
30 SEPTEMBER31 MARCH%
20162016CHANGE
Capital Return
NAV
– debt at par742.25p710.74p+4.4
– debt at market value725.36p695.30p+4.3
Share price(1)724.00p665.00p+8.9
FTSE All-Share Index(1)3,755.343,395.19+10.6
Discount
– debt at par2.5%6.4%
– debt at market value0.2%4.4%
Gearing (at par):
– gross gearing(2)15.3%12.9%
– net gearing(3)15.0%12.8%
Annual change in Retail Price Index(1)2.0%1.6%

%
FOR THE SIX MONTHS TO 30 SEPTEMBER20162015CHANGE
Revenue Return
Revenue return per share13.9p13.9p+0.0
First interim dividend(4)5.4p5.2p+3.8

Notes: 1. Source: Thomson Reuters Datastream.

2. Gross gearing: borrowings (at par) ÷ shareholders’ funds.

3. Net gearing: borrowings (at par) less cash and cash equivalents ÷ shareholders’ funds.

4. Dividends declared in respect of the financial year.

INTERIM MANAGEMENT REPORT INCORPORATING THE CHAIRMAN’S STATEMENT

Dear Shareholder,

These six month results are reported against a backdrop of the EU referendum and the (then) upcoming US presidential election. The consequences, whether favourable or unfavourable, are likely to dominate the political and economic landscape for some years to come.

The UK equity market, after an initial fall following the surprise referendum result, rallied strongly and both the FTSE 100 index (benefiting from weak sterling) and the more domestically oriented FTSE 250 index recovered strongly to reach all time highs. Good index returns, however, mask some radical disparities in sector performance and our portfolio, whilst recording positive returns, lagged the benchmark index due in large part to strong performance in some stocks and sectors we do not hold. Further details and commentary are contained in the Manager’s Report which follows.

Our portfolio manager Mark Barnett, with an unchanged strategy, continues to focus on long term performance. I am pleased to report that James Goldstone, who has been working in the Manager’s UK equity team for the last four years, has been appointed deputy manager of the Company’s portfolio to work alongside Mark.

Performance

The Company produced a positive net asset value (NAV) total return for the six months to 30 September 2016 of 6.8% (debt at par) and 6.6% (debt at market), compared to a return of 12.9% by the FTSE All-Share Index, the Company’s benchmark. The share price total return (share price with dividends reinvested) for the period was 11.1%, with the Company’s share price ending the period at 724.0p, an increase of 8.9% from the year end share price of 665.0p.

The demand for shares in the market resulted in the discount (with NAV at par) of the Company narrowing from 6.4% at the year end to 2.5% on 30 September 2016. With debt at market value, the shares at this time were trading at a discount of 0.2% (31 March 2016: 4.4%). At 21 November 2016, the latest practical date prior to signing this report, the share price of 699.5p was at a 0.4% discount to the NAV (debt at market value) of 702.3p and a 2.6% discount to the NAV (debt at par) of 717.9p.

The portfolio continues to be concentrated in a relatively small number of sectors and its overweight or underweight positions in various sectors can be material drivers of the Company’s relative investment performance.

Dividend

As in previous years, the Board continues the exercise to rebalance the interim and final dividends, whilst simultaneously aiming to at least maintain the final dividend. Consequently, the Board has declared a first interim dividend of 5.4p (2015: 5.2p), an increase of 3.8%. This will be paid on 30 November 2016 to shareholders on the register on 18 November 2016, with shares quoted ex-dividend on 17 November 2016.

The Board, and the portfolio managers, remain cognisant of the Company’s objective to grow the dividend payable to shareholders by more than the rate of UK inflation over the long term.

By this time last year, the Company had earned over £3 million of special dividends which contributed substantially to total dividend income for the six months of £30.3 million. Special dividends by their nature are not recurring, so it should be no surprise that none were earned in the six months being reported. However, partly countering this, dividend income in aggregate benefited from the fall in sterling. I am pleased to report that the portfolio has generated over £30.7 million of dividend income with the result that revenue return per share for the period matches that of the comparable six months to September 2015 of 13.9p.

Borrowings and Gearing

The Company has in place a mixture of fixed and floating rate debt. The former is the Company’s £100 million 7¾% debenture which matures in 2022 and the latter a £150 million, 364 day bank credit facility. By this means, Mark has the ability to vary the gearing level of the portfolio depending on his view of the market. During the period under review aggregate borrowings ranged between £180 million and £228 million, and ended the period at £222.8 million – equivalent to gross gearing of 15.3% (debt at par).

Outlook

The fallout from both the EU referendum result and the US election makes it more difficult than usual to predict future economic and market trends with any confidence. One can comfortably justify caution in relation to UK equities on valuation grounds, albeit that yields are likely to continue to provide support while bonds look even more expensive. The Board remains confident that Mark’s high conviction approach to investment, driven by careful stock selection, is right for such uncertain times. The approach will inevitably lead to portfolio performance that will diverge from that of the index and, as we have seen this half year, may result in periods of underperformance, especially in sharply rising markets. However, the focus as in the past remains on adding significant value over the long term.

Jim PettigrewChairman23 November 2016

MANAGER’S REPORT

Market Review

After a volatile start to 2016, the UK stock market rose strongly over the six month period to 30 September 2016. This was driven initially by rising commodity prices and “dovish” central bank monetary policy and then, following the Brexit referendum, by the sharp fall in sterling. There was significant divergence in sector performance during the period, with share price falls after the referendum seen most acutely in certain domestically focused sectors whereas the share prices of companies with US dollar denominated earnings rose strongly in anticipation of upgrades to forecast earnings. The resources sectors (oil and mining) performed notably well over the period, as crude oil continued to rise from its February price lows, recently on news that OPEC members had proposed production cuts, and the continued rally in commodity prices buoyed global mining companies.

Alongside the Brexit effect, the UK stock market’s attention remained focused on the timing of the next increase in US interest rates, which was generally perceived as being postponed until December.

Sector volatility moderated towards the period end, with the share prices of domestically focused companies showing some recovery. The Bank of England’s 0.25% cut in interest rates met expectations, but the broader language around monetary stimulus went further than many in the market had anticipated. Economic data provided some more encouraging signs for the UK economy: September’s Purchasing Manager’s Index indicated confidence in British business, with rises in services output and new business following August’s declines.

Portfolio Strategy and Review

The Company’s net asset value, including reinvested dividends, rose by 6.8% (debt at par) and 6.6% (debt at market value) during the period under review, compared with a rise of 12.9% by the FTSE All-Share Index.

Against a strong market backdrop, the Company delivered a positive return, but failed to match the rise of the benchmark index. The Company’s performance was held back by its zero weighting in the mining sector and the absence of a holding in HSBC and Royal Dutch Shell. These share prices rose strongly, benefiting from weakened sterling (which declined by 8.8% against the US dollar over the period) and, in the case of Royal Dutch Shell, from the recovering oil price. The zero weighting in UK domestic banks was, however, beneficial to portfolio performance.

The holdings in the tobacco sector again delivered a positive contribution to performance, helped by their international exposure, but also from continued positive news flow. British American Tobacco is seeing the benefits of its focus on key brands – its Global Drive Brands posted a 10.5% volume increase in its Q2 earnings report. Imperial Brands’ half year results confirmed a 10% interim dividend increase as it reaps further benefits from last year’s acquisition in the US of brands (including Winston) and manufacturing facilities.

AstraZeneca, another US dollar beneficiary, announced plans to file its injectable asthma treatment drug with US and European regulators later this year, after favourable trial results. The failure of Bristol-Myers’ lung cancer study was also seen as positive for AstraZeneca’s combination therapy cancer drugs.

Other significant positive contributions to portfolio performance came from the holdings in BP, Burford Capital, Compass, HomeServe and Rentokil Initial.

The portfolio’s holdings in domestic sectors, notably those particularly exposed to the fall in sterling and perceived challenges to the UK economy, performed poorly in the aftermath of the referendum. The stock market was also inclined to de-rate companies which warned of lower profits – delivering a “double-whammy” impact on the share price via a fall in both earnings forecast and P/E ratios. 

Notable amongst these was the holding in Capita, which fell sharply in value as it downgraded full-year earnings forecasts, blaming a slow-down in specific trading businesses, one-off costs and problems with a major contract with TFL – along with delayed client decision-making since the EU referendum.

The holdings in the travel sector – easyJet and Thomas Cook – warned of the negative impact of weaker sterling and were additionally impacted over the period by concerns over terrorist activity and by air traffic control strikes. There was some respite for Thomas Cook shareholders towards period end as the company confirmed full year profit guidance. The benefits of the measures the company has taken over the past two years are offsetting a challenging trading environment.

Other domestically focused holdings to deliver negative share price performance included Derwent London, N Brown, GAME Digital, BT and TalkTalk Telecom.

The share price of Circassia Pharmaceuticals fell sharply on news that its cat allergy drug had failed to meet the primary end point of Phase III trials. While this was very disappointing and surprising news – the drug had performed well in Phase II trials – it is noteworthy that Circassia Pharmaceuticals retains significant cash on its balance sheet and that, over the past year, the company has also made significant diversification into respiratory drugs, devices and technologies. 

In terms of portfolio activity during the period, new investments were made in Next, Secure Trust Bank and Hadrians Wall Secured Investments. The remaining holding in Reckitt Benckiser was sold.

Outlook

It is likely that the near term outlook for the UK equity market will continue to be dictated by the movement of global bond prices and the sterling/US dollar exchange rate. These asset markets have exerted a major influence on UK equities over the course of 2016. The strong performance of the bond market, not always associated with a rising equity market, and the perceived benefit from the drop in sterling have been the driving forces behind the ongoing re-rating of UK equities to reach a current PE valuation of 17.5x forecast 2016 EPS. This valuation looks full, particularly relative to the disappointing overall level of underlying profit growth recorded this year (excluding the impact of sterling and the commodity bounce back). It is highly unlikely that the re-rating of UK equities will continue unchecked against a backdrop of higher valuations and ongoing pressure on corporate profitability. It is noticeable how the rate of profit warnings across the market has increased in the past few weeks. In addition, the recent reversal of bond markets has put pressure on valuations in certain sectors.

There are several challenges which may force a reassessment of the current valuations that are being applied to the UK equity market. The first is the lack of overall profit growth, which, absent a significant devaluation in sterling, would have seen another year of no growth in 2016. The underlying earnings outlook for next year looks similarly muted. Second, a more difficult near-term UK economic picture is likely to emerge. The reappearance of inflation – largely as a result of the movement in sterling – will pressurise consumer budgets and hinder overall levels of economic growth. This factor, coupled with the ongoing uncertainty over the political path to Brexit, may put a brake on UK employment levels and investment intentions, further moderating activity in the domestic economy. To some extent, this has been priced into equities, as the performance disparity between global and domestic companies since the referendum has been significant. Nevertheless, the backdrop to corporate profitability is unlikely to ease over the coming year as pricing power remains elusive.

The political backdrop has the potential to deliver more surprises over the coming year, a third factor likely to continue to exert major influence on both corporate behaviour and stock market performance. The election of Donald Trump as the next US president has already set off widespread expectations of fiscal reflation with knock-on effects in certain stock market sectors. The domestic political scene is currently overshadowed by the new government’s evolving political agenda, while internationally, there are a series of important elections on the horizon; the potential for a sudden policy shift or unexpected election results is significant.

Finally, a shift in the value of global bonds also has the potential to de-stabilise the outlook for UK equities. This could emanate from US policy tightening or simply a realisation that the extreme low yields reached over the summer months across the world no longer represent a realistic view of the medium term outlook for inflation and interest rates. Indeed, at the time of writing, we are witnessing a meaningful shift upwards in 10 year bond yields.

Navigating any of these obstacles, either individually or in combination, will continue to be challenging. The most important discipline is to remain vigilant about valuation. Notwithstanding the elevated level of stock market valuation, there are bottom-up opportunities for the long-term investor, which have started to emerge as a result of the substantial sector rotations that have occurred since the June referendum. Where new bottom-up opportunities arise, the emphasis will continue to be on companies that can demonstrate a sustainable top line growth and translate that into profit, free cash flow and dividends without excessive financial leverage.

Mark Barnett James GoldstonePortfolio Manager Deputy Portfolio Manager

23 November 2016

Total Returns to 30 September 2016

6 MONTHS1 YEAR2 YEARS3 YEARS5 YEARS10 YEARS
NAV (debt at par) (%)6.810.523.739.799.6118.7
NAV (debt at market value) (%)6.610.724.341.5108.9131.5
Share Price (%)11.18.528.034.896.6160.7
FTSE All-Share Index (%)12.916.814.121.168.975.6

Source: Thomson Reuters Datastream.

Principal Risks and Uncertainties

The principal risk factors relating to the Company can be summarised as follows:

• Market Risk – a fall in the stock market as a whole will affect the performance of the portfolio, as well as the performance of individual portfolio investments; it also includes interest rate and currency risks; market risk may be impacted by increased volatility during the period of uncertainty following the EU referendum;

• Investment Performance Risk – this is the stock specific risk that the stock selection process may not achieve the Company’s published objectives;

• Gearing and Borrowing Risk – in addition to the debenture in issue, the Company may also borrow money for investment purposes. If the investments fall in value, the gearing will have an adverse impact on performance. If the borrowing facility could not be renewed, the Company might have to sell investments to repay this;

• Income/Dividend Risk – investment income may fail to reach the level required to meet the Company’s income objective;

• Share Price Risk – the Company’s prospects and NAV may not be fully reflected in the share price;

• Control Systems Risk – the Board relies on the effectiveness of the Manager’s control systems which include control activities in fund management operations, financial controls, meeting regulatory requirements and managing relations with third parties;

• Reliance on Manager and other Third Party Providers Risk – the Company has no employees, so is reliant upon the performance of third party service providers for it to function, particularly the Manager, depositary, custodian and registrar; and

• Other Risks – the Company may be affected by other risks such as business, cyber security, strategic, policy and political risks, as well as regulatory risks (such as an adverse change in the tax treatment of investment companies) and the perceived impact of the Manager ceasing to be involved with the Company.

A detailed explanation of these principal risks and uncertainties can be found on pages 9 to 12 of the 2016 annual financial report, which is available on the Company’s section of the Manager’s website at www.invescoperpetual.co.uk/edinburgh.

In the view of the Board, these principal risks and uncertainties are substantially unchanged from the previous year end and are as much applicable to the remaining six months of the financial year, as they were to the six months under review. The risk associated with failure of the custodian is mitigated by the appointment of the depositary. The depositary is ultimately responsible for safekeeping of the Company’s custodial assets and is strictly liable for the recovery of these in the event of loss.

As highlighted in the annual financial report, the Manager’s style may result in a concentrated portfolio. In addition, the Manager manages other portfolios holding many of the same stocks as the Company which reflects the Manager’s high conviction style of investment management. This could potentially increase liquidity risk under certain scenarios and market conditions.

Going Concern

These financial statements have been prepared on a going concern basis. The Directors consider this is the appropriate basis as the Company has adequate resources to continue in operational existence for the foreseeable future being at least 12 months after the date of approval of these half year financial statements. In considering this, the Directors took into account the diversified portfolio of readily realisable securities which can be used to meet funding commitments, and the ability of the Company to meet all its liabilities and ongoing expenses from its assets and revenue.

Related Party Transactions

Under UK Generally Accepted Accounting Practice (UK Accounting Standards and applicable law), the Company has identified the Directors as related parties. No other related parties have been identified. No transactions with related parties have taken place which have materially affected the financial position or the performance of the Company.

Directors’ Responsibility Statement

IN RESPECT OF THE PREPARATION OF THE HALF-YEARLY FINANCIAL REPORT

The Directors are responsible for preparing the half-yearly financial report using accounting policies consistent with applicable law and UK Accounting Standards.

The Directors confirm that to the best of their knowledge:

• the condensed set of financial statements has been prepared in accordance with the FRS 104 Interim Financial Reporting; and

• the interim management report includes a fair review of the information required by Disclosure Guidance and Transparency Rules (DTR):

(a) DTR 4.2.7R, being an indication of important events that have occurred during the first six months of the financial year and their impact on the condensed set of financial statements; and a description of the principal risks and uncertainties for the remaining six months of the year; and

(b) DTR 4.2.8R, being related party transactions that have taken place in the first six months of the current financial year and that have materially affected the financial position or performance of the Company during that period; and any changes in the related party transactions described in the last annual report that could do so.

Signed on behalf of the Board of Directors.

Jim PettigrewChairman

23 November 2016

INVESTMENTS IN ORDER OF VALUATIONAT 30 SEPTEMBER 2016UK listed and ordinary shares unless stated otherwise.AIM Investments quoted on AIM.

MARKET
VALUE% OF
INVESTMENTSECTOR£’000PORTFOLIO
Reynolds American –
US common stockTobacco 92,479 5.5
British American TobaccoTobacco 92,003 5.5
AstraZenecaPharmaceuticals & Biotechnology 78,520 4.7
Imperial BrandsTobacco 78,059 4.7
BPOil & Gas Producers 74,426 4.5
Provident FinancialFinancial Services 62,753 3.8
BTFixed Line Telecommunications 61,602 3.7
BAE SystemsAerospace & Defence 59,876 3.6
Roche – Swiss common stockPharmaceuticals & Biotechnology 58,489 3.5
Altria – US common stockTobacco 57,774 3.5
Ten Top Holdings715,98143.0
Legal & GeneralLife Insurance 47,539 2.8
RELXMedia 43,322 2.6
London Stock ExchangeFinancial Services 41,206 2.5
Babcock InternationalSupport Services 41,054 2.5
CompassTravel & Leisure 39,861 2.4
Rentokil InitialSupport Services 38,088 2.3
CentricaGas, Water & Multiutilities 37,377 2.2
HiscoxNon-life Insurance 37,324 2.2
BTGPharmaceuticals & Biotechnology 36,190 2.2
SSEElectricity 35,383 2.1
Twenty Top Holdings1,113,32566.8
Novartis – Swiss common stockPharmaceuticals & Biotechnology 35,328 2.1
NewRiver REITReal Estate Investment Trusts 35,145 2.1
ShaftesburyReal Estate Investment Trusts 30,225 1.8
CapitaSupport Services 27,587 1.7
Smith & NephewHealth Care Equipment & Services 25,697 1.6
BeazleyNon-life Insurance 25,560 1.5
DraxElectricity 25,330 1.5
G4SSupport Services 25,140 1.5
BCA MarketplaceFinancial Services 23,299 1.4
Derwent LondonReal Estate Investment Trusts 22,109 1.3
Thirty Top Holdings1,388,74583.3

MARKET
VALUE% OF
INVESTMENTSECTOR£’000PORTFOLIO
NextGeneral Retailers 21,508 1.3
easyJetTravel & Leisure 21,091 1.3
LancashireNon-life Insurance 19,787 1.2
HomeServeSupport Services 19,483 1.2
Burford CapitalAIMFinancial Services 17,588 1.1
TalkTalk TelecomFixed Line Telecommunications 17,416 1.0
KCOMFixed Line Telecommunications 17,309 1.0
IP GroupFinancial Services 14,161 0.8
P2P Global InvestmentsEquity Investment Instruments 13,435 0.8
CLSReal Estate Investment & Services 12,165 0.7
Forty Top Holdings1,562,68893.7
Thomas CookTravel & Leisure 12,091 0.7
ReddeAIMFinancial Services 11,914 0.7
Zegona CommunicationsNon-Equity Investment Instruments 10,482 0.6
Secure Trust BankAIMBanks 10,279 0.6
VecturaPharmaceuticals & Biotechnology 9,982 0.6
Raven Russia – OrdinaryReal Estate Investment & Services 5,364
Raven Russia – Preference 3,8130.6
 9,177
N BrownGeneral Retailers 7,516 0.5
Honeycomb Investment TrustEquity Investment Instruments 6,750 0.4
GAME DigitalGeneral Retailers 6,333 0.4
VPC Specialty Lending
InvestmentsFinancial Services 6,147 0.4
Fifty Top Holdings1,653,35999.2
Circassia PharmaceuticalsPharmaceuticals & Biotechnology 5,089 0.3
Hadrians Wall Secured
InvestmentsEquity Investment Instruments 4,201 0.3
Funding Circle SMEEquity Investment Instruments 3,359 0.2
Eurovestech – UnquotedFinancial Services 396
Melrose IndustriesConstruction & Materials 273
Proximagen – Rights 12 Sept
2017UnquotedPharmaceuticals & Biotechnology 173
Barclays Bank – Nuclear Power
Notes 28 Feb 2019Non-Equity Investment Instruments 34
Total Holdings (57) 1,666,884 100.0

CONDENSED INCOME STATEMENT

SIX MONTHS TO 30 SEPTEMBER 2016
(UNAUDITED)
REVENUECAPITALTOTAL
£’000£’000£’000
Gains on investments66,94866,948
Foreign exchange losses(68)(68)
Income – note 230,68154631,227
30,68167,42698,107
Investment management fee – note 3(1,130)(2,638)(3,768)
Other expenses(447)(1)(448)
Net return before finance costs
and taxation29,10464,78793,891
Finance costs – note 3(1,389)(3,242)(4,631)
Return on ordinary activities before taxation27,71561,54589,260
Tax on ordinary activities – note 4(433)(433)
Return on ordinary activities after taxation
for the financial period27,28261,54588,827
Return per ordinary share – basic13.9p31.5p45.4p
Number of ordinary shares in issue during
the period195,666,734

The total column of this statement represents the Company’s profit and loss account, prepared in accordance with UK Accounting Standards. The return on ordinary activities after taxation is the total comprehensive income and therefore no additional statement of comprehensive income is presented. The supplementary revenue and capital columns are presented for information purposes in accordance with the Statement of Recommended Practice issued by the Association of Investment Companies. All items in the above statement derive from continuing operations. No operations were acquired or discontinued in the period.

SIX MONTHS TO 30 SEPTEMBER 2015
(UNAUDITED)
REVENUECAPITALTOTAL
£’000£’000£’000
Losses on investments(10,081)(10,081)
Foreign exchange losses(28)(28)
Income – note 2 30,317 30,317
 30,317(10,109) 20,208
Investment management fee – note 3(1,099)(2,565)(3,664)
Other expenses(424)(1)(425)
Net return before finance costs
and taxation 28,794(12,675) 16,119
Finance costs – note 3(1,315)(3,068)(4,383)
Return on ordinary activities before taxation 27,479(15,743) 11,736
Tax on ordinary activities – note 4(360)(360)
Return on ordinary activities after taxation
for the financial period27,119(15,743)11,376
Return per ordinary share – basic13.9p(8.1)p5.8p
Number of ordinary shares in issue during
the period195,116,734

CONDENSED RECONCILIATION OF MOVEMENTS IN SHAREHOLDERS’ FUNDS

CAPITAL
SHARESHAREREDEMPTIONCAPITALREVENUE
CAPITALPREMIUMRESERVERESERVERESERVETOTAL
£’000£’000£’000£’000£’000£’000
FOR THE SIX MONTHS ENDED
30 SEPTEMBER 2016
(UNAUDITED)
At 31 March 201648,91710,39424,6761,239,84768,4831,392,317
Dividends paid – note 5(27,296)(27,296)
Net return on ordinary activities61,54527,28288,827
At 30 September 201648,91710,39424,6761,301,39268,4691,453,848
FOR THE SIX MONTHS ENDED
30 SEPTEMBER 2015
(UNAUDITED)
At 31 March 201548,7796,63924,6761,232,29163,5661,375,951
Dividends paid – note 5(26,829)(26,829)
Net return on ordinary activities(15,743)27,11911,376
At 30 September 201548,7796,63924,6761,216,54863,8561,360,498

CONDENSED BALANCE SHEETRegistered number SC1836

ATAT
30 SEPTEMBER31 MARCH
20162016
(UNAUDITED)(AUDITED)
£’000 £’000
Fixed assets
Investments held at fair value through
profit or loss1,666,8841,563,534
Current assets
Amounts due from brokers1,387
Prepayments and accrued income2,2724,491
Tax recoverable1,4841,581
Cash and cash equivalents4,1421,981
9,2858,053
Creditors: amounts falling due within one year
Amounts due to brokers(120)(24)
Bank facility(122,800)(80,000)
Accruals(907)(878)
(123,827)(80,902)
Net current liabilities(114,542)(72,849)
Total assets less current liabilities1,552,3421,490,685
Creditors: amounts falling due after
more than one year
73/4% Debenture Stock 30 Sep 2022(98,494)(98,368)
Net assets1,453,8481,392,317
Capital and reserves
Share capital48,91748,917
Share premium10,39410,394
Capital redemption reserve24,67624,676
Capital reserve1,301,3921,239,847
Revenue reserve68,46968,483
Shareholders’ funds1,453,8481,392,317
Net asset value per ordinary share
Basic – note 6742.25p710.74p

NOTES TO THE CONDENSED FINANCIAL STATEMENTS

1. Accounting policies

The condensed financial statements have been prepared in accordance with applicable United Kingdom Accounting Standards and applicable law (UK Generally Accepted Accounting Practice), including FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland, FRS 104 Interim Financial Reporting and the Statement of Recommended Practice Financial Statements of Investment Trust Companies and Venture Capital Trusts, issued by the Association of Investment Companies in November 2014. The financial statements are issued on a going concern basis.

In March 2016, the Financial Reporting Council published amendments to FRS 102 – Fair value hierarchy disclosures. These amendments become effective for accounting periods beginning on or after 1 January 2017. The Company has chosen to early adopt these amendments. There are no accounting policy or disclosure changes as a result of this adoption.

The accounting policies applied to these condensed financial statements are consistent with those applied in the financial statements for the year ended 31 March 2016.

2. Income

SIX MONTHS TOSIX MONTHS TO
30 SEPT30 SEPT
20162015
(UNAUDITED)(UNAUDITED)
£’000£’000
Income from listed investments
UK dividends – ordinary26,39222,398
UK dividends – special3,175
Overseas dividends – ordinary3,7183,188
Scrip dividends1,257
Unfranked investment income567138
Income from money market funds34
30,68030,160
Other income
Deposit interest12
Underwriting commission155
Total income30,68130,317

Special dividends of £546,000 were recognised in capital (2015: £nil).

3. Management fee and finance costs

The management fee arrangements are as reported in the 2016 annual financial report, being a flat fee of 0.0458333% of the market capitalisation of the Company’s ordinary shares at each month end. This equates to 0.55% per annum. The management fee and finance costs are allocated 30% to revenue and 70% to capital.

4. Tax

Owing to the Company’s status as an investment company no tax liability arises on capital gains. The tax charge represents withholding tax suffered on overseas income.

A deferred tax asset is not recognised in respect of surplus management expenses since the Directors believe that there will be no taxable profits in the future against which these can be offset.

5. Dividends

SIX MONTHS TOSIX MONTHS TO
30 SEPT30 SEPT
20162015
(UNAUDITED)(UNAUDITED)
PENCE£’000PENCE£’000
Dividends paid:
Third interim5.2010,1755.1510,049
Final8.7517,1218.6016,780
13.9527,29613.7526,829

A first interim dividend of 5.4p (2015: 5.2p) for the year ended 31 March 2017, will be paid on 30 November 2016.

6. Net asset value (NAV) per ordinary share

(a) Debt at par

The shareholders’ funds in the balance sheet are accounted for in accordance with accounting standards, however, this does not reflect the rights of shareholders on a return of assets under the Articles of Association. These rights are reflected in the net assets with debt at par and the corresponding NAV per share.

30 SEPT31 MAR
20162016
(UNAUDITED)(AUDITED)
PENCE PER SHAREPENCE PER SHARE
Shareholders’ funds743.02711.58
Less: unamortised discount and expenses
arising from debenture issue(0.77)(0.84)
NAV – debt at par742.25710.74

(b) Debt at market value

30 SEPT31 MAR
20162016
(UNAUDITED)(AUDITED)
PENCE PER SHAREPENCE PER SHARE
NAV – debt at par742.25710.74
Debenture debt at par51.1151.11
Debenture debt at market value(68.00)(66.55)
NAV – debt at market value725.36695.30

7. Classification Under Fair Value Hierarchy

The fair value hierarchy analysis for investments held at fair value at the period end is as follows:

30 SEPT31 MAR
20162016
(UNAUDITED)(AUDITED)
£’000£’000
Level 1 – The unadjusted quoted price in an active market
for identical assets or liabilities that the entity
can access at the measurement date1,666,2811,562,779
Level 2 – Inputs other than quoted prices included within
Level 1 that are observable (ie developed
using market data) for the asset or liability,
either directly or indirectly34120
Level 3 – Inputs are unobservable (ie for which market
data is unavailable) for the asset or liability569 635
1,666,884 1,563,534

Level 3 investments comprise the two unquoted investments held by the Company.

8. Share capital

30 SEPT31 MAR
20162016
(UNAUDITED)(AUDITED)
Allotted, called-up and fully paid
Number of ordinary shares of 25p each195,666,734195,666,734

As reported in the 2016 annual financial report, in December 2015 the Company issued 550,000 ordinary shares. No shares have been issued or bought back since this time.

9. It is the intention of the Directors to conduct the affairs of the Company so that it satisfies the conditions for approval as an investment trust company within the meaning of section 1158 of the Corporation Tax Act 2010.

10. The financial information contained within the financial statements in this half-yearly financial report has not been audited by the Company’s Auditor and does not constitute statutory accounts as defined in section 434 of the Companies Act 2006 (the ‘Act’).

The figures and financial information for the year ended 31 March 2016 are extracted and abridged from the latest published accounts and do not constitute the statutory accounts for that year. Those accounts have been delivered to the Registrar of Companies and included the Independent Auditor’s Report which was unqualified and did not contain a statement under either section 498(2) or 498(3) of the Act.

By order of the BoardInvesco Asset Management LimitedCompany Secretary23 November 2016

INDEPENDENT REVIEW REPORT

Introduction

We have been engaged by the Company to review the condensed set of financial statements in the half-yearly financial report for the six months ended 30 September 2016 which comprises the condensed income statement, the condensed reconciliation of movements in shareholders’ funds, the condensed balance sheet and the related explanatory notes. We have read the other information contained in the half-yearly financial report and considered whether it contains any apparent misstatements or material inconsistencies with the information in the condensed set of financial statements.

This report is made solely to the Company in accordance with the terms of our engagement to assist the Company in meeting the requirements of the Disclosure Guidance and Transparency Rules (the ‘DTR’) of the UK’s Financial Conduct Authority (the ‘UK FCA’). Our review has been undertaken so that we might state to the Company those matters we are required to state to it in this report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company for our review work, for this report, or for the conclusions we have reached.

Directors’ Responsibilities

The half-yearly financial report is the responsibility of, and has been approved by, the Directors. The Directors are responsible for preparing the half-yearly financial report in accordance with the DTR of the UK FCA.

As disclosed in note 1, the annual financial statements of the Company are prepared in accordance with UK Accounting Standards and applicable law (UK Generally Accepted Accounting Practice), including FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland. The condensed set of financial statements included in this half-yearly financial report has been prepared in accordance with FRS 104 Interim Financial Reporting.

Our Responsibility

Our responsibility is to express to the Company a conclusion on the condensed set of financial statements in the half-yearly financial report based on our review.

Scope of Review

We conducted our review in accordance with International Standard on Review Engagements (UK and Ireland) 2410 Review of Interim Financial Information Performed by the Independent Auditor of the Entity issued by the Auditing Practices Board for use in the UK. A review of interim financial information consists of making enquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (UK and Ireland) and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

Conclusion

Based on our review, nothing has come to our attention that causes us to believe that the condensed set of financial statements in the half-yearly financial report for the six months ended 30 September 2016 is not prepared, in all material respects, in accordance with FRS 104 Interim Financial Reporting and the DTR of the UK FCA.

Catherine Burnetfor and on behalf of KPMG LLPChartered Accountants­London 23 November 2016

Date   Source Headline
3rd May 202411:32 amRNSNet Asset Value(s)
2nd May 202411:15 amRNSNet Asset Value(s)
1st May 20241:22 pmRNSTotal Voting Rights
1st May 202411:39 amRNSNet Asset Value(s)
30th Apr 202411:15 amRNSNet Asset Value(s)
29th Apr 202411:29 amRNSNet Asset Value(s)
26th Apr 202411:31 amRNSNet Asset Value(s)
25th Apr 202411:09 amRNSNet Asset Value(s)
24th Apr 202411:40 amRNSNet Asset Value(s)
24th Apr 20247:00 amRNSDividend Declaration
23rd Apr 202411:03 amRNSNet Asset Value(s)
22nd Apr 20245:16 pmRNSTransaction in Own Shares
22nd Apr 202410:55 amRNSNet Asset Value(s)
19th Apr 202411:06 amRNSNet Asset Value(s)
18th Apr 202411:06 amRNSNet Asset Value(s)
18th Apr 20248:45 amRNSCompliance with Market Abuse Regulation
17th Apr 202410:56 amRNSNet Asset Value(s)
16th Apr 202410:42 amRNSNet Asset Value(s)
15th Apr 20245:09 pmRNSTransaction in Own Shares
15th Apr 20245:05 pmRNSDirector/PDMR Shareholding
15th Apr 202411:04 amRNSNet Asset Value(s)
15th Apr 20249:22 amRNSDirector Declaration
12th Apr 202410:54 amRNSNet Asset Value(s)
11th Apr 20245:12 pmRNSTransaction in Own Shares
11th Apr 202411:18 amRNSNet Asset Value(s)
10th Apr 20245:39 pmRNSTransaction in Own Shares
10th Apr 202410:41 amRNSNet Asset Value(s)
9th Apr 20245:24 pmRNSTransaction in Own Shares
9th Apr 202411:17 amRNSNet Asset Value(s)
8th Apr 20245:29 pmRNSTransaction in Own Shares
8th Apr 202410:18 amRNSNet Asset Value(s)
5th Apr 202410:58 amRNSNet Asset Value(s)
4th Apr 202411:24 amRNSNet Asset Value(s)
3rd Apr 20245:40 pmRNSTransaction in Own Shares
3rd Apr 202411:38 amRNSNet Asset Value(s)
2nd Apr 20245:29 pmRNSTransaction in Own Shares
2nd Apr 202411:31 amRNSNet Asset Value(s)
2nd Apr 202411:09 amRNSTotal Voting Rights
28th Mar 20245:28 pmRNSTransaction in Own Shares
28th Mar 202411:41 amRNSNet Asset Value(s)
27th Mar 20245:15 pmRNSTransaction in Own Shares
27th Mar 202411:09 amRNSNet Asset Value(s)
26th Mar 20245:31 pmRNSTransaction in Own Shares
26th Mar 20242:12 pmRNSDirector/PDMR Shareholding
26th Mar 202410:27 amRNSNet Asset Value(s)
25th Mar 20245:03 pmRNSTransaction in Own Shares
25th Mar 202410:45 amRNSNet Asset Value(s)
22nd Mar 20245:21 pmRNSTransaction in Own Shares
22nd Mar 202411:09 amRNSNet Asset Value(s)
21st Mar 20245:26 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.